
|Videos|February 18, 2016 (Updated: April 18, 2020)
- Gastrointestinal Cancers: mCRC (Issue 7)
- Volume 1
- Issue 7
Dr. Katherine Van Loon on Recognizing Recurrences in Gastrointestinal Cancers
Author(s)Katherine Van Loon, MD
Van Loon says that oncologists need further research into how often and for how long patients with gastrointestinal cancers should be monitored.
Katherine Van Loon, MD, gastrointestinal cancer specialist, University of California, San Francisco, discusses identifying recurrences in gastrointestinal cancers at a point where patients can receive further therapy.
Articles in this issue
about 10 years ago
Neoadjuvant Therapy Continues to Evolve for Pancreatic Cancerabout 10 years ago
ERCC1 Expression Falls Short as Chemo Biomarker in mCRCabout 10 years ago
Panitumumab Boosts Overall Survival in Chemorefractory mCRCabout 10 years ago
Two Options Allows for Treatment Tailoring in Refractory CRCabout 10 years ago
FOLFOXIRI Bests FOLFOX as Bevacizumab Backbone in mCRCRelated Content
Advertisement





Encorafenib Combo Boosts PFS in BRAF V600E+ Metastatic Colorectal Cancer
Published: | Updated:



























